Cell Drive develops a patented modular bioink platform that enables the on-demand production of living tissues through 3D bioprinting, utilizing synthetic bioinks that promote cell adhesion without crosslinkers or photoinitiators. This technology addresses the need for biocompatible and biodegradable materials in tissue engineering and regenerative medicine, facilitating the creation of in vitro tissue models and drug delivery systems.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of creating living tissues for biomedical applications often require crosslinkers or photoinitiators, which can compromise cell viability and limit the long-term stability of 3D-printed structures. The need for biocompatible and biodegradable materials that promote cell adhesion without these additives remains a challenge in tissue engineering and regenerative medicine.
Solution
Cell Drive offers a patented modular bioink platform that enables the on-demand production of living tissues through 3D bioprinting. Their synthetic bioinks are engineered using recombinant DNA technology and based on human elastin sequences, mimicking the extracellular matrix to maximize cell viability. The bioinks promote cell adhesion and ensure long-term stability of printed structures without the need for crosslinkers or photoinitiators. This technology facilitates the creation of in vitro tissue models and drug delivery systems, offering a biomimetic, biocompatible, and biodegradable solution for advanced biomedical applications.
Target Audience
The primary audience includes researchers and companies in tissue engineering, regenerative medicine, and drug development who require biocompatible materials for 3D bioprinting applications.
Features
- Patented modular technology for developing translational bioinks for 3D bioprinting.
- Synthetic bioinks capable of promoting cell adhesion without crosslinkers or photoinitiators.
- Animal-free formulation mimicking the extracellular matrix.
- Available in three different concentrations (low, medium, and high) to control the stiffness of 3D-printed structures.
- Supplied sterile and ready to use.
- Suitable for 3D-printing scaffolds embedded with cells for in vitro tissue models.
- Can be used to encapsulate drug-loaded nanoparticles for drug screening and drug delivery.